文献速递腹部技术与安全CT

基于影像组学预测结直肠癌微卫星不稳定性:一种用于治疗分层的无创方法

Radiomics-based prediction of microsatellite instability in colorectal cancer: a non-invasive approach to treatment stratification.
PubMed 文献 · Radiol Med · 2025-09-02

影像组学模型有潜力作为无创、经济有效的工具用于MSI评估,辅助识别可从免疫治疗或化疗中获益的患者,支持治疗从术后向术前转变。

要点

  • 门静脉期增强CT影像组学模型可无创预测结直肠癌MSI状态,最佳模型AUC为0.844(95%CI=0.73-0.96)。
  • 每个模型筛选出20个有统计学意义的影像组学特征用于区分MSI与MSS患者。
  • 模型按不同CT机器品牌分别构建,提示设备差异可能影响影像组学特征稳定性。

核心结论

  • 影像组学模型有潜力作为无创、经济有效的工具用于MSI评估,辅助识别可从免疫治疗或化疗中获益的患者,支持治疗从术后向术前转变。

研究设计与样本

  • 回顾性分析54例成人结直肠癌患者,术前分期采用增强CT并已知MSI状态;评估门静脉期图像,两名对MSI状态设盲的放射科医生手动分割肿瘤区域;采用影像组学特征和统计建模构建预测MSI-H表型的模型,并按不同CT机器品牌分别构建两个模型。

临床应用与阅片要点

  • 作者认为影像组学模型可作为无创、经济有效的工具用于MSI评估,辅助识别可从免疫治疗或化疗中获益的患者,支持治疗从术后向术前转变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Management of colorectal cancer (CRC) is determined by the stage of the disease and molecular features, such as microsatellite instability (MSI). MSI-high/deficient mismatch repair (MSI-H/dMMR) tumors respond better to immunotherapy but poorly to 5-FU-based treatments. With increasing use of neoadjuvant chemotherapy there is interest in developing non-invasive, radiomics models based on preoperative contrast-enhanced CT scans to predict MSI status and support personalized therapy.

MATERIAL AND METHODS: Adult patients diagnosed with CRC who underwent pre-treatment staging with contrast-enhanced CT and had known MSI status were retrospectively analyzed. Portal venous phase images were assessed. Two radiologists, blinded to MSI status, manually segmented tumor regions on CT images. Radiomic features and statistical modeling were used to develop a predictive model for identifying the MSI-H phenotype.

RESULTS: Analysis was conducted on 54 adult CRC patients who had undergone staging CT scans with known MSI status. Two different models were built considering different brands of CT machines. Twenty statistically significant radiomic features from the portal venous phase of CT images able to differentiate MSI from microsatellite stable (MSS) patients were selected for each model. LASSO regression was applied, selecting features for model construction. The best model's performance demonstrated an area under the ROC curve of 0.844 (95% CI = 0.73-0.96 DeLong, p < 0,05).

CONCLUSION: The results demonstrate the potential of the radiomics model as a non-invasive, cost-effective tool for MSI evaluation, guiding CRC therapy. It aids in identifying patients who would benefit from immunotherapy or chemotherapy, supporting the therapeutic shift from postoperative to preoperative treatment.

来源:Radiol Med,查看原文。版权归原作者所有。

引用

  1. Mallardi D, Danti G, Galluzzo A, et al. Radiomics-based prediction of microsatellite instability in colorectal cancer: a non-invasive approach to treatment stratification. Radiol Med. 2025. PMID: 40892331. doi:10.1007/s11547-025-02081-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。